Measures and Methods for Research on Family Caregivers for People Living with Alzheimers Disease and Related Dementias (AD/ADRD) (R21 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-23-023 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites Exploratory/Developmental Grants (R21) applications for the development of methods and measures for capturing expanded definitions of family and related concepts relevant to informal caregiving for people living with Alzheimers disease (AD) and Alzheimers disease related dementias (ADRD), and for the testing of these measures in populations underrepresented in AD/ADRD research. This FOA and RFA-AG-23-022 are companion announcements. RFA-AG-23-022 invites Research Project Grant (R01) applicat...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 9, 2022 Category: Research Source Type: funding
Measures and Methods for Research on Family Caregivers for People Living with Alzheimers Disease and Related Dementias (AD/ADRD) (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-23-022 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites Research Project Grant (R01) applications for the development of methods and measures for capturing expanded definitions of family and related concepts relevant to informal caregiving for people living with Alzheimers disease and Alzheimers disease related dementias (AD/ADRD), and for the implementation of these measures in new and existing studies. High risk/high payoff projects that lack preliminary data may be more appropriate for FOA RFA-AG-23-023. RFA-AG-23-023 invites Exploratory/Devel...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 9, 2022 Category: Research Source Type: funding
Notice of Special Interest (NOSI): Administrative Supplements to Support Research Infrastructure on Exposome Studies in Alzheimer's Disease (AD) and AD-Related Dementias (ADRD)
Notice NOT-AG-22-022 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 1, 2022 Category: Research Source Type: funding
Policy and Alzheimers Disease (AD) and Alzheimers Disease-Related Dementias (ADRD) Healthcare Disparities: Access, Utilization, and Quality (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-23-024 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits Research Project Grant (R01) applications for projects designed to exploit variations (e.g., geographic, temporal) in social and health care policies to employ experimental, quasi-experimental, or other innovative approaches to uncover mechanisms driving disparities in care (i.e., access, utilization, and quality) for persons living with Alzheimers disease and Alzheimers disease related dementias (AD/ADRD). (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 6, 2022 Category: Research Source Type: funding
Neuronal Vulnerability to Proteinopathies in Alzheimers Disease and Alzheimers Disease-Related Dementias (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-23-028 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to define and characterize neuronal and glial cell populations that are vulnerable to Alzheimer's disease (AD) and AD-related dementias (ADRD) proteinopathies. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 19, 2022 Category: Research Source Type: funding
Request for Information (RFI) on Capacity and Support Needed to Increase Community-Based Research Networks Participation in Alzheimers Disease and Related Dementias (AD/ADRD) Clinical Trials
Notice NOT-AG-22-018 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 9, 2022 Category: Research Source Type: funding
Noncoding RNAs in Alzheimers Disease and Related Dementias (R21 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-23-011 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to stimulate research in noncoding ribonucleic acids (ncRNAs) to investigate the causality, directionality, mechanisms, and therapeutic potential of ncRNAs implicated in Alzheimer's disease and Alzheimer's disease related dementias (AD/ADRD). This FOA will support exploratory and developmental Grant (R21) applications seeking to discover functional roles of ncRNAs and underlying mechanisms involved in the pathogenesis and progression of AD/ADRD. Proposed studies should focus on functi...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 28, 2022 Category: Research Source Type: funding
Noncoding RNAs in Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-23-010 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to stimulate research in noncoding ribonucleic acids (ncRNAs) to investigate the causality, directionality, mechanisms, and therapeutic potential of ncRNAs in Alzheimer's disease and Alzheimer's disease related dementias (AD/ADRD). This FOA will support applications seeking to discover novel mechanisms mediated by ncRNAs, elucidate molecular, and cellular functions involved in the pathogenesis and progression of AD/ADRD. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 28, 2022 Category: Research Source Type: funding
Mechanisms of Brain Hypoperfusion in AD/ADRD (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-23-014 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits applications for projects designed to understand molecular and cellular mechanisms underlying cerebral blood flow reduction in Alzheimers disease (AD) and Alzheimers disease-related dementias (ADRD). (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 22, 2022 Category: Research Source Type: funding
Health Equity and the Cost of Novel Treatments for Alzheimers Disease and Related Dementias (R61/R33 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-23-005 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites R61/R33 applications that address health equity, drug costs, and access to new therapeutics or repurposed drugs for Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). Successful applications will seek to identify preferences for pharmacological treatment among racial and ethnic minority people living with AD/ADRD, assess whether cost barriers to pharmacological care exist for racial and ethnic minority people living with AD/ADRD, and quantify expenditures and health- re...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 17, 2022 Category: Research Source Type: funding
Notice to Clarify the Research Objectives of PAR-21-360 "Pilot Studies for the Spectrum of Alzheimers Disease/Alzheimers Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional)"
Notice NOT-AG-22-015 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 14, 2022 Category: Research Source Type: funding
NIA Renewal and Revision Cooperative Agreements in AD/ADRD Research (U24 Clinical Trial Not Allowed)
Funding Opportunity PAR-22-110 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) allows for renewal and competitive revision applications, and their resubmissions, for funded U24?Research Resource/Infrastructure?applications?that?support?large-scale, complex research programs focused on?Alzheimers disease (AD) and?Alzheimers disease-related dementias (ADRD).?It is anticipated that such programs will likely involve a team of investigators within a single institution or a consortium of?institutions?and?align with one or more?AD/ADRD implementation research milestones?supporting the?r...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 3, 2022 Category: Research Source Type: funding
Notice of Correction to Award Project Period Information for PAS-19-317, "Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
Notice NOT-AG-22-012 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 24, 2022 Category: Research Source Type: funding
Notice of Correction to Award Project Period Information for PAS-19-316, "Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)
Notice NOT-AG-22-011 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 24, 2022 Category: Research Source Type: funding
Pilot Studies for the Spectrum of Alzheimers Disease/Alzheimers Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional)
Funding Opportunity PAR-21-360 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to 1) invite research grant applications that enable the collection of pilot data to support early stage testing of promising pharmacological and non-pharmacological interventions for cognitive and neuropsychiatric changes associated with age-related cognitive decline and Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD) across the spectrum from pre-symptomatic to more severe stages of disease, and 2) stimulate studies to enhance trial design and methods. (Sour...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 10, 2022 Category: Research Source Type: funding
